Mint Tower Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,000
Closed -$899K 155
2017
Q3
$899K Buy
+5,000
New +$697K 0.29% 29

Mint Tower Capital Management's KITE Position: Q4 2017 in Review

Mint Tower Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 5,000 shares — an estimated $899K sold.

Mint Tower Capital Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $899K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Mint Tower Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Mint Tower Capital Management sold 5,000 Kite Pharma, Inc. shares in Q4 2017, an estimated $899K.
  • Mint Tower Capital Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Mint Tower Capital Management's Kite Pharma, Inc. position peaked at $899K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Mint Tower Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.